Company: NUTR
Filing Date: 2025-04-14
Form Type: S-1/A
Source: 0001641172-25-004581
Chunk: 57

Company: NUSATRIP Inc
Filing Date: 2025-04-14
Form: S-1/A
Chunk 57
---
 as of December 31, 2024 would have been US$7,738,293 or approximately $0.58 per outstanding share of Common Stock to existing stockholders and an immediate dilution in tangible book value of $3.92 per share, to purchasers of common stock in this offering. The following table illustrates such dilution:

| Public Offering Price                                                                                                         |     | $ |       4.50 |   |
| Historical net tangible book value (deficit)                                                                                  
 as of December 31, 2024                                                                                                       |     |   | (5,981,709 | ) |
| Increase in pro forma                                                                                                         
 net tangible book value attributable to pro forma adjustments described above on the sale of 3,750,000 shares of common stock 
 in IPO of US$4.5 per share after deducting underwriting discounts and estimated offering expenses                             |     | $ | 15,225,000 |   |
| Pro forma net tangible book value as of December 31, 2024                                                                     |     | $ |  9,243,291 |   |
| Increase in pro forma                                                                                                         
 as adjusted net tangible book value attributable to investors participating in this offering to be paid for the conversion of 
 the Convertible Notes of 1,066,668 shares of common stock at an assumed price of $1.50                                        |     | $ |  1,600,002 |   |
| Pro forma as adjusted net tangible book                                                                                       
 value immediately after this offering                                                                                         |     | $ | 10,843,293 |   |
| Dilution per share                                                                                                            
 to new investors in this offering                                                                                             |     | $ |       3.92 |   |

| 39 |

The pro forma as adjusted dilution information discussed above is illustrative only and will depend on the actual public offering price and other terms of this offering determined at pricing.

The following table summarizes, on a pro forma as adjusted basis as of December 31, 2024, the total number of shares 18,816,668 of Common Stock purchased from us, the sales of 3,750,000 shares of our common stock in this offering (assuming no exercise of the over-allotment option to purchase additional shares of common stock and assuming no exercise of the Representative’s Warrants), the total cash consideration paid to us, and the average price per share paid by existing stockholders and by investors in the IPO. The table below reflects an assumed initial public offering